Xcovery is a biopharmaceutical company with the aim to improve the lives of cancer patients by discovering and developing innovative medicines to fight advanced tumors. We are working on a pipeline of oncology therapies to target a wide range of malignant diseases. Our lead product, ensartinib (X-396), is a small molecule that inhibits anaplastic lymphoma kinase (ALK). Ensartinib is being investigated for the treatment of ALK positive non-small cell lung cancer. We are currently enrolling patients in our phase 2 and phase 3 clinical studies. Xcovery.com
Looking for a particular Xcovery employee's phone or email?
The Xcovery annual revenue was $10 million in 2026.
Fuqiang Liu is the Executive Vice President of Xcovery.
16 people are employed at Xcovery.
Xcovery is based in Palm Beach Gardens, Florida.
The NAICS codes for Xcovery are [3254, 325, 32, 32541].
The SIC codes for Xcovery are [28, 283].